Edwards Lifesciences Corporation (Edwards Lifesciences) announced the Court of Appeals for the Federal Circuit affirmed a previous court decision in favor of Cook Inc. and W. L. Gore & Associates, finding the companies did not infringe Edwards' patents for modular or multi-part endovascular grafts for treatment of abdominal aortic aneurysms (AAA).

While Edwards expressed disappointment over the court’s ruling, it said that the ruling does not impact any of its businesses because the company discontinued its AAA product line in April 2006. Another co-defendant in this case settled with Edwards in January 2006 under terms including a payment of $37.5 million.

Edwards Lifesciences provides products and technologies used for the treatment of patients suffering from advanced cardiovascular disease.